2006 Archive

December 18, 2006

Delcath Announces Resignation of M. S. Koly as CEO and Appointment of Richard Taney as Interim CEO

November 20, 2006

Delcath Systems Appoints Richard Taney as New Independent Director

November 20, 2006

Delcath Systems Issues Third Quarter Update

October 26, 2006

Delcath Systems to Present at the C.E. Unterberg, Towbin Life Sciences Conference

October 23, 2006
Delcath Systems Announces the Resignation of Victor Nevins From the Board of Directors

October 6, 2006

Delcath Addresses Recent Share Price Decline

October 3, 2006

TRIAL DATE SET IN FEDERAL SECURITIES LAWSUIT AGAINST LADDCAP

September 27, 2006

Laddcap Counterclaim Against Delcath Dismissed And Temporary Restraining Order Against Laddcap Modified In Federal Securities Lawsuit

September 26, 2006

Delcath Systems Appoints New Independent Director

September 20,2006
Preliminary Injunction Hearing In Federal Securities Lawsuit Against Laddcap Adjourned to October 2, 2006

September 15, 2006
Proxy Advisor Questions Laddcap Nominees’ Experience and Recommends Against Giving Control of Delcath’s Board to Laddcap

August 29, 2006
Delcath Systems Invites Shareholders to Submit Questions for Town Hall Meeting

August 25, 2006
Delcath Systems to Host a Special “Town Hall” Meeting with Shareholders in Stamford, CT

August 21, 2006

August 18, 2006
Delcath Systems Announces a New Site for the Phase III Doxorubicin Clinical Trial in San Antonio, TX

August 18, 2006

August 16, 206
Delcath Systems Retains C.E. Unterberg, Towbin as Strategic Advisor

August 7, 2006
Delcath Systems Files Securities Lawsuit Against Laddcap

July 28, 2006
Delcath Systems Advises Stockholders to Defer Taking Any Action at This Time in Response to Laddcap's Announced Consent Solicitation

July 17, 2006
Delcath Systems Issues Second Quarter Update

July 11, 2006
Delcath Systems Announces Laddcap's Withdrawal of Request for Special Meeting of Shareholders

July 5, 2006
Delcath Systems Announces Listing on Russell Microcap Index

June 27, 2006
Delcath Systems Issues Letter to Shareholders

June 13, 2006
Delcath Systems Featured in Clinical Journal of Oncology Nursing

June 13, 2006
Delcath Systems Announces Results of Annual Shareholder Meeting

June 12, 2006
Delcath Systems Responds to Shareholder Proposal; Affirms Commitment to Maximizing Long-term Shareholder Value

March 1, 2006
Delcath Systems Announces Initial Patient Treatment In Phase III Clinical Trial

February 22, 2006
Delcath Systems Receives Special Protocol Assessment and Agreement from FDA

February 7, 2006
Delcath Systems Receives NCI Institutional Review Board Approval

January 26, 2006
Delcath Systems to Present at Brean Murray, Carret & Co. Small Cap Institutional Investor Conference

January 24, 2006
Delcath Systems Co-Sponsors First International Symposium On Regional Cancer Therapies

January 4, 2006
New Principal Investigator to Conduct Delcath Clinical Trials at NCI